AU4399197A - Hepatitis c virus epitope - Google Patents

Hepatitis c virus epitope

Info

Publication number
AU4399197A
AU4399197A AU43991/97A AU4399197A AU4399197A AU 4399197 A AU4399197 A AU 4399197A AU 43991/97 A AU43991/97 A AU 43991/97A AU 4399197 A AU4399197 A AU 4399197A AU 4399197 A AU4399197 A AU 4399197A
Authority
AU
Australia
Prior art keywords
hepatitis
virus epitope
epitope
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43991/97A
Inventor
Keiichi Makizumi
Kyosuke Mizuno
Tsukasa Nishihara
Shinichiro Nishimura
Chikateru Nozaki
Tetsuji Rikihisa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of AU4399197A publication Critical patent/AU4399197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU43991/97A 1996-10-14 1997-10-03 Hepatitis c virus epitope Abandoned AU4399197A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP8-293359 1996-10-14
JP29335996 1996-10-14
JP06544897A JP2002171972A (en) 1996-10-14 1997-03-03 Hepatitis kanen virus epitope
JP9-65448 1997-03-03
PCT/JP1997/003551 WO1998016647A1 (en) 1996-10-14 1997-10-03 Hepatitis c virus epitope

Publications (1)

Publication Number Publication Date
AU4399197A true AU4399197A (en) 1998-05-11

Family

ID=26406591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43991/97A Abandoned AU4399197A (en) 1996-10-14 1997-10-03 Hepatitis c virus epitope

Country Status (3)

Country Link
JP (1) JP2002171972A (en)
AU (1) AU4399197A (en)
WO (1) WO1998016647A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
AU2002211885A1 (en) * 2000-10-11 2002-04-22 Xoma Technology Ltd. Antifungal peptides
AU2002243259B2 (en) * 2000-12-01 2008-02-07 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006247A1 (en) * 1991-09-16 1993-04-01 Abbott Laboratories Hepatitis c assay
ES2287969T3 (en) * 1992-03-06 2007-12-16 Innogenetics N.V. HIV PEPTIDES
WO1994014974A1 (en) * 1992-12-29 1994-07-07 Akzo Nobel N.V. Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus
DE19504302A1 (en) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Method for serological typing using type-specific antigens
US6110465A (en) * 1995-06-07 2000-08-29 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines

Also Published As

Publication number Publication date
JP2002171972A (en) 2002-06-18
WO1998016647A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU2064297A (en) Hepatitis c virus ribozymes
AU2550995A (en) Hepatitis c virus asialoglycoproteins
AU6304996A (en) Vaccines against hepatitis c
AU4878096A (en) Hepatitis b vaccine
AU4781297A (en) Vaccines
AU3434393A (en) Targeted virus
AU2272997A (en) Software anti-virus facility
GB9415369D0 (en) Mutant virus
AUPM411994A0 (en) Epitopes
AU3714499A (en) Hepatitis c virus mimotopes
AU2645297A (en) Hepatitis b monoclonal antibodies
AUPO026596A0 (en) Viral peptide
AU5679394A (en) Hepatitis b virus vaccines
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
AU1773099A (en) Materials for virus capture
AU3552797A (en) Vaccine preparations
AU4399197A (en) Hepatitis c virus epitope
AU688259B2 (en) Hepatitis C virus peptides
AU1991095A (en) Activating virus
AU7336296A (en) Human hepatitis b virus dna
AU7334498A (en) Hepatitis b virus mutations
AU2679797A (en) Improved utilization of virus
AU3072395A (en) Polyepitope vaccines
AU1950797A (en) Vacuum attachment
AU4156096A (en) Non-infective vaccines